Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00779155 · ClinicalTrials.gov registry record · Phase 2

Study of Magnetic Fields for Treatment of Parkinson's Disease

A Phase 2 study of Parkinson's Disease, sponsored by pico-tesla Magnetic Therapies.

Completed
Registry status
Phase 2
Development phase
12
Enrollment target
1
Study location

NCT00779155: Completed Phase 2 study of Parkinson's Disease, sponsored by pico-tesla Magnetic Therapies.

NCT00779155 is a Phase 2 study of Parkinson's Disease that has completed, run by pico-tesla Magnetic Therapies. The registered enrollment target is 12 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00779155, a Phase 2 study of Parkinson's Disease, has completed, sponsored by pico-tesla Magnetic Therapies.

COMPLETED
Registry status
Phase 2
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if low level magnetic fields may help to relieve symptoms of Parkinson's disease.

Primary Outcome

The UPDRS is used to measure different aspects of Parkinson's Disease (PD). The UPDRS subscale II assesses how PD affects a person's daily life, with scores ranging from 0-52, with 52 representing greatest severity. The UPDRS subscale III assesses how PD affects how a person moves about, with scores ranging from 0-108, with 108 representing greatest severity. The combination of these 2 scores is used in clinical trials and in clinical practice to get a good overall idea of how PD affects a perso

Conditions Studied

Parkinson's Disease

Interventions

  • DEVICE The Resonator
  • DEVICE The Resonator control

Study Locations (1)

Colorado

  • pico-tesla Magnetic Therapies - Littleton

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2007-08
Est. Completion 2009-06
Phase Phase 2
pico-tesla Magnetic Therapies

3 total trials

What the finished NCT00779155 record still lists

NCT00779155 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which The Resonator is the first listed.

NCT00779155 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT00779155 about?

NCT00779155 is a clinical study titled "Study of Magnetic Fields for Treatment of Parkinson's Disease". The purpose of this study is to determine if low level magnetic fields may help to relieve symptoms of Parkinson's disease.

What is the current status of trial NCT00779155?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2007-08. Estimated completion is 2009-06.

What conditions does trial NCT00779155 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT00779155?

The interventions under investigation include: The Resonator (DEVICE), The Resonator control (DEVICE).

Who is sponsoring clinical trial NCT00779155?

This trial is sponsored by pico-tesla Magnetic Therapies, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00779155 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00779155's enrollment target sits among peer trials

12 143rd of 158 higher than 15 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00779155, the US trial registry maintained by the National Library of Medicine. NCT00779155 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.